Risk Factors of Covid-19 Confirmed Died Patients in Dr. Kariadi Hospital: A Retrospective Study

Elyana Sri Sulistyowati, Septi Sewi Muninggar, Verarica Silalahi

= http://dx.doi.org/10.20473/ijtid.v9i1.22609
Abstract views = 1308 times | downloads = 571 times


Covid-19 is a communicable disease causing global pandemic. Some factors inflict worse infection. This study aims to investigate risk factors of Covid-19 confirmed died patients at Dr. Kariadi Hospital Semarang. It is a retrospective study with a total sample of all Covid-19 confirmed patients involving died and healed patients from March to June 2020. Data was gathered from screening forms and analysed with Chi Square (confidence interval of 95%). This study found sixteen risk factors of Covid-19 confirmed died patients involving age (p= 0.000; OR= 8.803; 95% CI 3.982-19.462), entrepreneur (p= 0.041; OR= 14.894; 95% CI 1.12-198.65), farmer/trader (p= 0.029; OR= 25.625; 95% CI 1.40-469.25), contact history (p= 0.000; OR= 12.923; 95% CI 6.163-27.097), fever (p= 0.000; OR= 4.877; 95% CI 2.647-8.984), dyspnea (p=0.000; OR= 17.018; 95% CI 8.523-33.977), cough (p= 0.009; OR= 2.178; 95% CI 1.205-3.935), lethargic (p=0.010; OR= 2.282; 95% CI 1.205-4.323), cold (p= 0.002; OR= 0.180; 95% CI 0.054-0.600), diabetes (p=0.000; OR= 9.767; 95% CI 3.932-24.263), COPD (p= 0.001; OR= 6.360; 95% CI 2.164-18.690), hypertension (p= 0.043; OR= 2.436; 95% CI 1.008-5.887), cancer (p=0.001; OR= 9.647; 95% CI 2.413-38.579), heart disease (p= 0.000; OR= 12.226; 95% CI 2.4-62.294), neurological disorders (p=0.008; OR= 6.057; 95% CI 1.650-22.232), and immune disorders (p=0.031; OR= 1.625; 95% CI 1.186-113.899). Adequate handling is needed to prevent death. in patients with confirmed Covid-19 who have risk factors.


risk factor; confirmed patients; Covid 19; died; retrospective

Full Text:



Centers for Disease Control and Prevention (CDC). Novel Coronavirus (2019-nCoV) [Internet]. 2020. [cited 2020 July 9]

Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS. MERS and Novel Coronavirus (Covid-19) Epidemics. The Newest and Biggest Global Health Threats: What Lessons have We Learned? International Journal of Epidemiology. 2020; 1–10. DOI: 10.1093/ije/dyaa033

Kahn LH. Commentary on: The SARS. MERS and Novel Coronavirus (Covid-19) Epidemics. The Newest and Biggest Global Health Threats: What Lessons have We Learned? A One Health Approach to Coronaviruses. International Journal of Epidemiology. 2020; 1–3 doi: 10.1093/ije/dya a071

The Health Ministry of Indonesia. The decree of health ministry No HK.01.07/Menkes/413/2020 about guidance for prevention of Coronavirus disease 2019 (Covid-19). Jakarta; 2020

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical Course and Risk Factors for Mortality of Adult Inpatients with Covid-19 in Wuhan. China: a Retrospective Cohort Study. Lancet. 2020; 395(10229):1054-62. Epub 2020/03/15

Susilo A, Rumende MC, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan, Sinto R et al. Coronavirus Disease 2019: A literature review. Jurnal Penyakit Dalam Indonesia. 2020; 7(1): 45-67. doi: 10.7454/jpdi.v7i1.415

WHO. Transmision of SARS-CoV-2: Implication toward infection prevention awareness [Internet]. 2020. [cited 2020 July 22]. Available from: https://www.who.int/docs/defaultsource/searo/indone sia/covid19/transmisi-sars-cov-2implikasiuntuk terhadap-kewaspadaan-pencegahan-infeksi-pernya taan-keilmuan.pdf?sfvrsn=1534d7df_4

WHO. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. 2020. [cited 2020 Juli 9]. Available from: https://covid19.who.int/ Accessed on 9 Juli 2020

Health Ministry. Covid-19 cases in Indonesia Dashboard [Internet]. 2020. [cited 2020 July 21]. Available from: https://www.kemkes.go.id/ article/view/20031900002/Dashboard-Data-KasusCOVID-19-di-Indonesia.html

Stand F, Jöckel K, Stang A. COVID‑19 and the Need of Targeted Inverse Quarantine. European Journal of Epidemiology. 2020; 35:339–340. doi: 10.1007/s10654020-00629-0

Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers AL. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerging Infectious Diseases. 2020; 26 (6): 1341-1342. doi: 10.3201/eid2606.200357

The Health Ministry of Indonesia. Coronavirus Disease (Covid-19) prevention and control guidance. Jakarta: General directorate of disease prevention and control; 2020

Guo RF. A Flaw on a Meta-Analysis of Smoking and the Severity of Covid-19: The Association should have been Endorsed. Journal of Public Health. 2020; 42(3):653– 654. doi: 10.1093/pubmed/fdaa083

WHO. Scientific Brief: Smoking and Covid-19 [Internet].2020. [cited 2020 July 22]. Available from: https://www.who.int/newsroom/commentaries/detail/smo king-and-covid-19

Ardiaria M. The role of Vitamin D for influenza and Covid-19 prevention. JNH (Journal of Nutrition and Health). 2020; 8(2): 79-85.doi: 10.14710/jnh.8.2. 2020.79-85

Mahajan UV, Larkins-Pettigrew M. Racial demographics and COVID-19 Confirmed Cases and Deads: a Correlational Analysis of 2886 US Counties. Journal of Public Health. 2020; 1–4. DOI:10.1093/pubmed/fdaa070

Trias-Llimós S, Bilal U. Impact of the COVID-19 Pandemic on Life Expectancy in Madrid (Spain). Journal of Public Health. 2020; 1–2. doi: 10.1093/pubmed /fdaa087

Onder G, Rezza G, Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID19 in Italy. JAMA. 2020; E1. doi:10.1001/jama .2020.4683

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with Covid-19 in Wuhan. China: a Retrospective Cohort Study. Lancet. 2020; 395: 1054-1062. doi: 10.1016/ S0140-6736(20)30566-3

Harlem G. Descriptive Analysis of Social Determinant Factors in Urban Communities Affected by COVID-19. Journal of Public Health. 2020; 1–4. doi:10.1093/pub med/fdaa078

Nie Y, Li J, Huang X, Guo W, Zhang X, Ma Y et al. Epidemiological and Clinical Characteristics of 671 COVID-19 Patients in Henan Province. China. International Journal of Epidemiology. 2020; 1–11. doi: 10.1093/ije/dyaa081

Lai CKC, Ng RWY, Wong MCS, Chong KC, Yeoh YK, Chen Z et al. Epidemiological Characteristics of the First 100 Cases of Coronavirus Disease 2019 (Covid-19) in Hong Kong Special Administrative Region. China. a City With a Stringent Containment Policy. International Journal of Epidemiology. 2020; 1–10. doi: 10.1093/ije /dyaa106

Gémes K, Talbäck M, Modig K, Ahlbom A, Berglund A, Feychting AA et al. Burden and Prevalence of Prognostic Factors for Severe COVID‑19 in Sweden. European Journal of Epidemiology. 2020;35:401–409. doi: https://doi.org/10.1007/s10654-020-00646-z

WHO. Advocacy Brief: Gender and Covid-19 [Internet]. 14 May 2020. [cited 2020 July 22]. Available from: https://www.who.int/publications/i/item/gender-andcovid-19

Alobuia WM, Dalva-Baird NP, Forrester JD, Bendavid E, Bhattacharya J, Kebebew E. Racial Disparities in Knowledge. Attitudes and Practices Related to COVID19 in the USA. Journal of Public Health. 2020; 1–9. doi:10.1093/pubmed/fdaa069

Mutambudzi M, Niedwiedz C, Macdonald EB, Leyland A, Mair F, Anderson J, Celis-Morales C, Cleland J, Forbes J, Gill J, Hastie C, Ho F, Jani B, Mackay DF, Nicholl B, O’Donnell C, Sattar N, Welsh P, Pell JP, Katikireddi SV, Demou E. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup. Environ. Med. 2020;0:1–8. doi:10.1136/oemed-2020-106731

Office for National Statistics. Coronavirus (COVID-19) related deaths by occupation, before and during lockdown, England and Wales: deaths registered between 9 March and 30 June 2020. Statistical bulletin. 2020;1-20

Prevention CfDCa. Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential Coronavirus Disease 2019 (COVID-19) Exposures: Geographic Risk and Contacts of Laboratory-confirmed Cases [Internet]. 2020. [cited 2020 July 23]. Available from: https://www.cdc.gov/ coronavirus/2019-ncov/php/risk-assessment.html

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine. 2020. doi: 10.1007/s42399-020-00363

Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the Extent of True Asymptomatic COVID-19 and Its Potential for Community Transmission: Systematic Review and Meta-Analysis.MedRxiv. 2020. doi:10.1101/2020.05.10.20097543

Qu G, Chen J, Huang G, Zhang M, Yu H, Zhu1 H, Chen L, Wang D, Pei B. A quantitative exploration of symptoms in COVID-19 patients: an observational cohort study. Int. J. Med. Sci. 2021; 18(4): 1082-1095. doi: 10.7150/ijms.53596

Oualha M, Bendavid M, Berteloot L, Corsia A, Lesage F, Vedrenne M et al. Severe and Fatal Forms of COVID-19 in Children. Archives de Pe´ diatrie. 2020; 27: 235–238. doi: 10.1016/j.arcped.2020.05.010.

Patel NA. Pediatric COVID-19: Systematic Review of the Literature. Am J Otolaryngol. 2020; 41:1-9. doi: 10.1016/j.amjoto.2020.102573


  • There are currently no refbacks.

Copyright (c) 2021 Indonesian Journal of Tropical and Infectious Disease

View My Stats

IJTID Indexed by : 


IJTID (pISSN 2085-1103eISSN 2356-0991is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Lembaga Penyakit Tropis (Institute of Tropical Disease)

Universitas Airlangga

Kampus C Mulyorejo

Surabaya 60115